-
'Very dangerous' super typhoon nears US Pacific islands
-
Taiwanese film hunters rescue ageing reels from bygone era
-
Australia stand by under-fire Popovic after World Cup exit
-
Trump arrives for US 250th birthday speech after storm delay
-
Afghan car trade screeches to a halt due to regional wars
-
All Blacks wing Fineanganofo's debut began 'in the toilet, spewing'
-
Pipe dreams: Bangladesh surfers chase waves at Asian Games
-
Xhaka -- Switzerland's World Cup rock born to be skipper
-
England can write new Azteca history by meeting Mexico challenge, says Tuchel
-
Trump pushes ahead with US 250th birthday speech after storm delay
-
Paraguay coach says team 'fought like lions' in World Cup loss to France
-
Australia's Schmidt rues missed opportunities as Wilson defends Donaldson
-
Violent crime wave beleaguers Israel's Arab youth
-
Deschamps hails France for staying cool in World Cup win over Paraguay
-
Severe weather disrupts Trump's America 250 celebration
-
Japan ready for Ireland after 'big statement' against Italy
-
Judge, Trout among MLB All-Star Game starter selections
-
Mbappe says France happy 'to get hands dirty' after World Cup win
-
Davis-Woodhall opens up about depression after Eugene win
-
France beat Paraguay with Mbappe penalty to reach World Cup quarter-finals
-
France battle past Paraguay to set up Morocco World Cup showdown
-
Ukraine denies Moscow claim of seizing strategic stronghold
-
Jefferson-Wooden holds off Richardson for Eugene 100m win
-
Dinusha shines for Sri Lanka on second day of West Indies Test
-
Stopping Haaland no mystery for Brazil, says Ancelotti
-
Julian Quinones, Mexico's not-so-secret World Cup weapon
-
Coach says Morocco 'no longer a surprise' after reaching World Cup quarters
-
Erasmus celebrates equalling record with win for weakened Springboks
-
Tuipulotu guides Scotland past Argentina with record score
-
'I'm going with him': families fear for bodies of Venezuela's quake dead
-
'Proud' Marsch says Canada better side in World Cup exit
-
Venezuela quake death toll rises to nearly 3,000
-
Norway must handle occasion against Brazil, says Solbakken
-
England unhappy with Rita Ora show before T20 World Cup final
-
Bethell upstages 'unbelievable' Sooryavanshi as England beat India
-
Morocco end Canada World Cup dream to reach quarters as France face Philly heat
-
'No point in racing' says frustrated Verstappen after British GP qualifying
-
Ruthless Morocco break Canadian hearts to reach World Cup quarters
-
Tour de France yellow gives Vingegaard crash closure
-
An 'angel' in darkness after Venezuela's deadly quakes
-
Smiling Antonelli proves all-round quality with pole at British GP
-
US turns 250 with Trump center stage
-
Vingegaard takes Tour de France lead with 'perfect start'
-
South Africa beat 13-man England in Nations Championship
-
Osaka eyes Sabalenka revenge in Wimbledon last 16
-
Vingegaard takes Tour de France lead as Visma win opening stage
-
Bethell upstages Sooryavanshi as England beat India in 2nd T20
-
Swiatek doesn't care about results after Wimbledon exit
-
Antonelli outpaces Ferraris to claim pole for British Grand Prix
-
England bid to emulate Lionesses and Red Roses in T20 World Cup final
Conflicting US rulings leave fate of abortion pill in doubt
Conflicting rulings by two federal judges have left the future of abortion pills in the United States deeply uncertain, likely placing the divisive issue squarely in the lap of the Supreme Court.
A ruling Friday by federal judge Matthew Kacsmaryk in Texas banned the widely used drug mifepristone (RU 486) nationwide, boosting conservatives' efforts to further restrict abortion rights after the Supreme Court last year allowed states to prohibit them.
The unprecedented rejection of a drug approved in 2000 by the US Food and Drug Administration (FDA) -- and found safe by scientific consensus -- sparked outrage on the political left.
Kacsmaryk, in his ruling, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
His ruling brought an immediate vow from the Biden administration and the drug's maker to appeal the matter in federal court.
Attorney General Merrick Garland said the Justice Department would ask the appeals court to stay the ban by Kacsmaryk, an ultraconservative Donald Trump appointee, until the case is finally resolved.
If the Texas ruling holds, it would complicate matters not just in the states now banning or sharply limiting abortions, but also in those where the procedure remains legal.
- Widely used -
Mifepristone has been used as part of a two-drug regimen by 5.6 million women since 2000.
But adding to the uncertainty and increasing the odds the matter ends up before the Supreme Court was a contradictory ruling from a Washington state judge that came just hours after Kacsmaryk's.
District Judge Thomas Rice, a Barack Obama appointee, ruled in a separate case -- brought by several states where abortion is legal -- that mifepristone is "safe and legal" and that the FDA must preserve access to it in more than a dozen states.
For now the drug remains legal, Alexis McGill Johnson, the head of Planned Parenthood, one of the largest pro-abortion groups in the country, said Friday.
Several abortion clinics also said Friday that they would continue using mifepristone until ordered not to by the FDA, US media reported.
Kacsmaryk paused the effect of his ruling for a week, allowing time for the administration and drugmaker Danco Laboratories to file before the US Fifth Circuit Court of Appeals in Louisiana, which hears cases from Texas.
The Justice Department is still reviewing Rice's ruling, Garland said in a statement.
- 'Remains safe' -
Given the sharply conflicting court rulings, the Justice Department might opt to take the case directly to the Supreme Court and not wait for the Fifth Circuit to act.
The high court could decide to take up the case on an emergency basis, which would require making room in an already crowded agenda at the end of the current term.
In that case, the court -- with six conservative justices outnumbering the three liberals -- could hear the case within days, or weeks, but sometime before the current session ends on June 30.
Chief Justice John Roberts, a conservative, is deeply protective of the image of the institution, and he might be expected to vote with the three liberals in favor of mifepristone. The additional vote of one other conservative could provide a majority for the drug.
The court's ruling last June to overturn the longstanding Roe v. Wade decision protecting abortion rights shifted considerable attention to medication abortions.
Most of them involve mifepristone in a two-drug regimen. A patient first takes a mifepristone pill to end the pregnancy, then a day later takes the drug misoprostol to induce contractions that expel the embryo or fetus.
Misoprostol can be used on its own to cause abortions, but the two-step procedure is considered more effective and can be more painful.
More than half of abortions in the US are done with medication.
Kacsmaryk, in his ruling, said the two-drug regimen had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective.
Michigan Governor Gretchen Whitmer, a Democrat, tweeted:
"Despite this ruling, I want to be clear: abortion, including medication abortion, remains safe and legal in the state of Michigan."
Women's March, which has been organizing organizing major women's rights demonstrations in recent years, called for a nationwide rally defending abortion rights for April 15.
D.Schneider--BTB